Vault-13

ENTERA BIO LTD ENTX

SHS · Common Stock · CUSIP M40527109

18 institutional holders +2 vs Q2 2024
5,323,2305.3m shares reported held*
14.5% of all shares outstanding*
$10.1mreported value*
3 new 3 added 3 reduced 1 sold out net bought ≈ $57.0k (+30.0k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 36.8m as of 2024-11-04, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $1.90. Options: 4 managers hold calls ($5.7k notional), 2 hold puts ($190).

Trends to Q3 2024

Institutional holders

Managers reporting a position, each quarter

01020Q3 22: 10Q4 22: 13Q1 23: 10Q2 23: 13Q3 23: 13Q4 23: 11Q1 24: 16Q2 24: 16Q3 24: 1818Q3 22Q1 23Q3 23Q1 24Q3 24
Numbers
QuarterHolders
Q3 202210
Q4 202213
Q1 202310
Q2 202313
Q3 202313
Q4 202311
Q1 202416
Q2 202416
Q3 202418

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
10010Q4 22: 6 bought or addedQ4 22: 2 cut or sold outQ1 23: 1 bought or addedQ1 23: 6 cut or sold outQ1 23Q2 23: 7 bought or addedQ2 23: 3 cut or sold outQ3 23: 6 bought or addedQ3 23: 6 cut or sold outQ3 23Q4 23: 5 bought or addedQ4 23: 5 cut or sold outQ1 24: 10 bought or addedQ1 24: 3 cut or sold outQ1 24Q2 24: 7 bought or addedQ2 24: 8 cut or sold outQ3 24: 6 bought or addedQ3 24: 4 cut or sold outQ3 24
Numbers
QuarterBought or addedCut or sold out
Q4 202262
Q1 202316
Q2 202373
Q3 202366
Q4 202355
Q1 2024103
Q2 202478
Q3 202464

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$10k$20k$30kQ4 23 calls: $24.6kQ4 23 puts: $0Q4 23P/C 0.00Q1 24 calls: $6.5kQ1 24 puts: $0Q1 24P/C 0.00Q2 24 calls: $736Q2 24 puts: $0Q2 24P/C 0.00Q3 24 calls: $5.7kQ3 24 puts: $190Q3 24P/C 0.03
Numbers
QuarterCallsPutsP/C
Q4 2023$24.6k$00.00
Q1 2024$6.5k$00.00
Q2 2024$736$00.00
Q3 2024$5.7k$1900.03

Biggest buyers

Biggest sellers

UBS Group AG Reduced -24,876-24.9k
Schonfeld Strategic Advisors LLC Reduced -23,158-23.2k
SUSQUEHANNA INTERNATIONAL GROUP, LLP Reduced -8,198-8.2k
SIMPLEX TRADING, LLC Sold out -260-260

Biggest calls

CITADEL ADVISORS LLC New $4.9k2.6k shares
GROUP ONE TRADING LLC Unchanged $760400 shares
CONCOURSE FINANCIAL GROUP SECURITIES, INC. Unchanged $00 shares
SIMPLEX TRADING, LLC Reduced $0300 shares

Biggest puts

CITADEL ADVISORS LLC New $190100 shares
CONCOURSE FINANCIAL GROUP SECURITIES, INC. Unchanged $00 shares

Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
BIOTECHNOLOGY VALUE FUND L P 13D · may seek influence new · filed 2026-08-04
Stated purposeThe Reporting Persons purchased the securities reported owned herein based on the Reporting Persons' belief that such securities, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable. April Securities Purchase Agreement and Registration Rights Agreement On April 1, 2026, … Full filing
10.0% new 17.2m≈ $30.5m 2026-08-04
OPKO HEALTH, INC. 13G · passive investor new · filed 2025-04-02 8.1% new 3.7m≈ $6.5m 2025-04-02
TCG Crossover GP III, LLC 13G · passive investor new · filed 2026-08-04 7.1% new 12.3m≈ $21.7m 2026-08-04
Vivo Opportunity Fund Holdings, L.P. 13G · passive investor new · filed 2026-08-04 6.9% new 11.8m≈ $20.9m 2026-08-04

Fell to 5% or below in the last year: Longitude Capital Partners V, LLC (4.6%, 2026-08-04), Seven Fleet Capital Management LP (4.1%, 2026-08-04)

Insider purchases and sales in Q3 2024

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
404Q4 22: 4 buyingQ4 22: 0 sellingQ1 23: 0 buyingQ1 23: 0 sellingQ1 23Q2 23: 1 buyingQ2 23: 0 sellingQ3 23: 3 buyingQ3 23: 0 sellingQ3 23Q4 23: 2 buyingQ4 23: 0 sellingQ1 24: 1 buyingQ1 24: 0 sellingQ1 24Q2 24: 0 buyingQ2 24: 0 sellingQ3 24: 0 buyingQ3 24: 0 sellingQ3 24
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q4 20224$100.8k0——
Q1 20230—0——
Q2 20231$30.3k0——
Q3 20233$47.0k0——
Q4 20232$17.0k0——
Q1 20241$15.3k0——
Q2 20240—0——
Q3 20240—0——

None reported in Q3 2024.

Holders, Q3 2024

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Knoll Capital Management, LLC 3.42% of their portfolio MIAMI, FL 3,881,8793.9m $7.4m $7.4m 3.42% Unchanged
2 Schonfeld Strategic Advisors LLC 0.01% of their portfolio NEW YORK, NY 648,600648.6k $1.2m $1.2m 0.01% Reduced -23.2k -23,158
3 Parkman Healthcare Partners LLC 0.10% of their portfolio STAMFORD, CT 411,076411.1k $781.0k $781.0k 0.10% Added +9.6k +9,558
4 UBS Group AG 0.00% of their portfolio ZURICH, V8 142,747142.7k $271.2k $271.2k 0.00% Reduced -24.9k -24,876
5 RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio NEW YORK, NY 61,20061.2k $116.3k $116.3k 0.00% Added +3.6k +3,600
6 SIGNATURE ESTATE & INVESTMENT ADVISORS LLC 0.00% of their portfolio LOS ANGELES, CA 47,32847.3k $89.9k $89.9k 0.00% New
7 SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio BALA CYNWYD, PA 20,65820.7k $39.2k $39.2k 0.00% Reduced -8.2k -8,198
8 CITADEL ADVISORS LLC 0.00% of their portfolio MIAMI, FL 20,55320.6k $39.1k $39.1k 0.00% New
9 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 17,59717.6k $33.4k $33.4k 0.00% Unchanged
10 OSAIC HOLDINGS, INC. 0.00% of their portfolio SCOTTSDALE, AZ 16,77716.8k $30.2k $30.2k 0.00% Unchanged
11 PNC Financial Services Group, Inc. 0.00% of their portfolio Pittsburgh, PA 13,00013.0k $24.7k $24.7k 0.00% Unchanged
12 CIBC WORLD MARKET INC. 0.00% of their portfolio TORONTO, A6 12,50012.5k $24.0k $24.0k 0.00% Unchanged
13 HighTower Advisors, LLC 0.00% of their portfolio CHICAGO, IL 11,83011.8k $22.0k $22.0k 0.00% Unchanged
14 NewEdge Advisors, LLC 0.00% of their portfolio NEW ORLEANS, LA 9,0009.0k $17.1k $17.1k 0.00% Unchanged
15 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 8,4308.4k $16.0k $16.0k 0.00% Added +5.4k +5,430
16 GROUP ONE TRADING LLC 0.00% of their portfolio CHICAGO, IL 5151 $97 $97 0.00% Unchanged
17 JPMORGAN CHASE & CO 0.00% of their portfolio NEW YORK, NY 44 $8 $8 0.00% New
18 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% Unchanged